Trade VOR stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Vor Biopharma Inc. (VOR) is trading at US$21.40, down 2.24% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$1.38B. Over the past 52 weeks, VOR has traded between US$6.50 and US$49.95. On Syfe you can trade VOR with $0 commission and add it to your watchlist.
| Previous close | US$21.89 |
|---|---|
| Market cap | US$1.38B |
| 52-week range | US$6.50 – US$49.95 |
| Volume | 3.73M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Vor Biopharma Inc.
Vor Biopharma, Inc. is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. It is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and potential commercialization to address serious autoantibody-driven conditions worldwide. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Boston, MA.
Year: 2021
Wedbush Adjusts Price Target on Vor Biopharma to $27 From $18, Keeps Neutral Rating
Aug 11, 2:58 PM · MT Newswires
Vor Biopharma Shares Drop After Q2 Results
Aug 11, 2:05 PM · MT Newswires
--Earnings Flash (VOR) Vor Biopharma Posts Q2 Net Loss $1.16 a Share, vs. FactSet Est of $0.70 Loss
Aug 11, 1:34 PM · MT Newswires
Vor Bio Partner Drug Earns Regulatory Approval In China For Sjogren's Disease
Jun 8, 1:30 PM · MT Newswires
Vor Biopharma Inc. (VOR) stock is trading at US$21.40, -2.24% from the previous close of US$21.89.
The market cap for Vor Biopharma Inc. (VOR) stock is approximately US$1.38B.
The 52-week high for Vor Biopharma Inc. (VOR) stock is US$49.95.
The 52-week low for Vor Biopharma Inc. (VOR) stock is US$6.50.
Vor Biopharma Inc. (VOR) does not currently pay a dividend.
Stay on top of VOR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
